Plasma Cell Neoplasm — Trials

Plasma Cell Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,420 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 51–54 of 54 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00652041	Bortezomib/Adriamycine/Melfalan/Prednisone (VAMP)/Thalidomide/Cyclophosphamide/Dexamethasone (TaCyDex) or Bortezomib/Melfalan/Prednisone (V-MP)/TaCyDex) in Refractary or Relapsed Multiple Myeloma(TaCyDexVMP7)	completed	Phase 4	40	PETHEMA FoundationOTHER	1	Sep 19, 2011	clinicaltrials
NCT00104104	A Multiple Myeloma Trial in Patients With Bone Metastases	completed	Phase 4	179	Novartis PharmaceuticalsINDUSTRY	1	Jun 29, 2011